Cooperations

Brandenburg has a strong and diverse expertise in the health sciences. With your support, we will develop a research atlas in which existing competences and infrastructures are brought together centrally and can be accessed easily. Our goal is to promote networking, scientific exchange and the establishment of joint collaborations in Brandenburg across institutions.
Webpage

The mission of the BIH is medical translation: The BIH aims to translate findings from biomedical research into new approaches for personalised prediction, prevention and therapy and, conversely, to develop new research approches from clinical observations.
Webpage

Brandenburg University of Technology Cottbus-Senftenberg
Prof. Dr. Friedrich Jung
Chair of Molecular Cell Biology
Molecular Cell Biology @ BTU

Prof. Dr. rer. nat. Axel T. Neffe
Chair of Organic chemistry with a focus on polymers
Organic cemistry with a focus on polymers @ BTU

Charité Universitätsmedizin Berlin
Prof. Dr. Ulf Landmesser
Medical Director Department of Cardiology, Angiology and Insensive Care Medicine
Prof. Dr. Ulf Landmesser @ Charité

Prof. Dr. med. Andreas Greiner
Director Department of Vascular Surgery and Head of Vascular Center
Prof. Dr. med. Andreas Greiner @ Charité

Martin-Luther-Universität Halle-Wittenberg
Prof. Dr. rer. nat. Christian Wischke
Biopharmacy-Group
Biopharmacy Group @ Uni Halle

Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class mRNA therapeutics.
Pantherna’s innovative technology platform has a focus on developing advanced nanoparticle solutions for the cell-selective delivery and expression of mRNA therapeutics. We are based in Hennigsdorf in the state of Brandenburg with laboratory facilities at the Bayer Pharma Campus in Berlin, Germany.
Webpage